Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Traditionally, men who chose radiation therapy for prostate cancer undergo radiation for weeks or even months. But now, in certain cases, it can be completed in less than a week. Prostate cancer ...

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

Formula One team owner Eddie Jordan has died, aged 76, after a year-long battle with prostate and bladder cancer. The Irishman revealed in December he was suffering from bladder and prostate ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common, with around 10,500 new cases. For both types, cancer can start in one area of the body and ...

Treating advanced cancer piles on the expenses at a time when your primary concern is comfort and recovery, whether it’s your own or that of your loved one. About 7 percent of prostate cancer ...

Prostate cancer statistics can look scary: 34,250 U.S. deaths in 2024. 1.4 million new cases worldwide in 2022. Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these ...

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...